212 related articles for article (PubMed ID: 8238647)
1. Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study.
Albus M; Scheibe G
Am J Psychiatry; 1993 Dec; 150(12):1878-80. PubMed ID: 8238647
[TBL] [Abstract][Full Text] [Related]
2. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Albus M; Scheibe G; Scherer J
Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
[TBL] [Abstract][Full Text] [Related]
3. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
Albus M; Scheibe G; Scherer J
J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
[TBL] [Abstract][Full Text] [Related]
4. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression.
Frank E; Shear MK; Rucci P; Cyranowski JM; Endicott J; Fagiolini A; Grochocinski VJ; Houck P; Kupfer DJ; Maser JD; Cassano GB
Am J Psychiatry; 2000 Jul; 157(7):1101-7. PubMed ID: 10873918
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
Brown C; Schulberg HC; Madonia MJ; Shear MK; Houck PR
Am J Psychiatry; 1996 Oct; 153(10):1293-300. PubMed ID: 8831437
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.
Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF
J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829
[TBL] [Abstract][Full Text] [Related]
7. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
Scheibe G; Albus M
J Affect Disord; 1996 Nov; 41(2):111-6. PubMed ID: 8961038
[TBL] [Abstract][Full Text] [Related]
8. Long-term course and outcome in panic disorder: a naturalistic follow-up study.
Cowley DS; Flick SN; Roy-Byrne PP
Anxiety; 1996; 2(1):13-21. PubMed ID: 9160594
[TBL] [Abstract][Full Text] [Related]
9. The impact of comorbidity on the treatment of panic disorder.
Lecrubier Y
J Clin Psychiatry; 1998; 59 Suppl 8():11-4; discussion 15-6. PubMed ID: 9707157
[TBL] [Abstract][Full Text] [Related]
10. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
[TBL] [Abstract][Full Text] [Related]
11. Treatment-resistant panic disorder.
Rosenbaum JF
J Clin Psychiatry; 1997; 58 Suppl 2():61-4; discussion 65. PubMed ID: 9078997
[TBL] [Abstract][Full Text] [Related]
12. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
13. A crossover study of focused cognitive therapy for panic disorder.
Beck AT; Sokol L; Clark DA; Berchick R; Wright F
Am J Psychiatry; 1992 Jun; 149(6):778-83. PubMed ID: 1590494
[TBL] [Abstract][Full Text] [Related]
14. Effects of co-occurring depression on treatment for anxiety disorders: analysis of outcomes from a large primary care effectiveness trial.
Campbell-Sills L; Sherbourne CD; Roy-Byrne P; Craske MG; Sullivan G; Bystritsky A; Lang AJ; Chavira DA; Rose RD; Shaw Welch S; Stein MB
J Clin Psychiatry; 2012 Dec; 73(12):1509-16. PubMed ID: 23290323
[TBL] [Abstract][Full Text] [Related]
15. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
16. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
Brown C; Schulberg HC; Shear MK
Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
[TBL] [Abstract][Full Text] [Related]
17. [Group psychotherapy in patients with panic disorder and agoraphobia].
Scheibe G; Albus M; Walther AU; Schmauss M
Psychother Psychosom Med Psychol; 1993 Jul; 43(7):238-44. PubMed ID: 8337352
[TBL] [Abstract][Full Text] [Related]
18. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
19. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
[TBL] [Abstract][Full Text] [Related]
20. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
